What are the transmission routes for Ureaplasma urealyticum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Ureaplasma is Transmitted

Ureaplasma urealyticum is primarily transmitted through sexual contact, with additional transmission occurring from mother to infant during pregnancy, delivery, or through the birth canal. 1, 2

Sexual Transmission in Adults

  • Sexual intercourse is the primary mode of transmission among sexually active adults, with colonization rates increasing directly with the number of different sexual partners 3, 4
  • Colonization rates are low (<10%) in sexually inexperienced adults and older children, but increase substantially following sexual debut 4
  • The organism colonizes the male urethra and female vagina as its primary sites, with other genital and nongenital mucosal sites colonized less frequently 4
  • Approximately one-third of healthy sexually experienced adults carry U. urealyticum as part of their normal urogenital flora 4

Perinatal Transmission Routes

Pregnant women transmit U. urealyticum to their newborns through three distinct pathways 5:

In Utero Transmission

  • Transplacental spread from the mother's bloodstream to the fetus 5
  • Ascending infection from the mother's colonized urogenital tract, even with intact fetal membranes—ureaplasmal infection of the amniotic sac without membrane rupture is well-documented 5

Intrapartum Transmission

  • Passage through a colonized birth canal during vaginal delivery 5
  • Vertical transmission occurs in 18-55% of full-term infants and 29-55% of preterm infants 5
  • Cesarean section does NOT prevent transmission—colonization occurs even with cesarean delivery and intact membranes 5, 6
  • Duration of membrane rupture (≥12 hours vs. <12 hours) does not significantly affect transmission rates 6

Postnatal Transmission

  • Horizontal or nosocomial transmission can occur after birth 5
  • Colonization persists in many infants: 68% of throat-colonized, 33% of eye-colonized, and 37% of vagina-colonized infants remain colonized at 3 months of age 6

Important Clinical Context

  • Transmission does not equal disease—U. urealyticum frequently colonizes healthy individuals without causing symptoms, existing in a "gray zone" where it is not classified as a traditional STD like gonorrhea or chlamydia 2
  • The presence of chorioamnionitis significantly increases vertical transmission rates from mother to infant 5
  • Very-low-birth-weight (VLBW) infants have higher colonization rates compared to term infants 5
  • Immunosuppressed patients are at increased risk of invasive infections when colonized 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ureaplasma Infection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Mycoplasma-induced urethritis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1980

Research

Perinatal transmission of Ureaplasma urealyticum: current concepts based on review of the literature.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.